AllianceBernstein’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $17.8M | Buy |
44,641
+322
| +0.7% | +$110K | 0.01% | 968 |
|
|
2025
Q4 | $17.6M | Buy |
44,319
+543
| +1% | +$240K | 0.01% | 997 |
|
|
2025
Q3 | $20M | Sell |
43,776
-23,355
| -35% | -$9.51M | 0.01% | 919 |
|
|
2025
Q2 | $21.9M | Buy |
67,131
+22,294
| +50% | +$6.17M | 0.01% | 871 |
|
|
2025
Q1 | $12.1M | Buy |
44,837
+247
| +0.6% | +$63.5K | ﹤0.01% | 1074 |
|
|
2024
Q4 | $10.5M | Sell |
44,590
-8,034
| -15% | -$2.11M | ﹤0.01% | 1167 |
|
|
2024
Q3 | $14.5M | Buy |
52,624
+7,251
| +16% | +$1.89M | ﹤0.01% | 1014 |
|
|
2024
Q2 | $11M | Sell |
45,373
-8,803
| -16% | -$1.39M | ﹤0.01% | 1120 |
|
|
2024
Q1 | $8.1M | Sell |
54,176
-466,663
| -90% | -$77.8M | ﹤0.01% | 1264 |
|
|
2023
Q4 | $99.7M | Sell |
520,839
-19,867
| -4% | -$3.38M | 0.04% | 406 |
|
|
2023
Q3 | $95.8M | Sell |
540,706
-9,573
| -2% | -$1.83M | 0.04% | 396 |
|
|
2023
Q2 | $105M | Buy |
550,279
+14,320
| +3% | +$2.84M | 0.04% | 378 |
|
|
2023
Q1 | $107M | Buy |
535,959
+464,775
| +653% | +$97.7M | 0.05% | 368 |
|
|
2022
Q4 | $16.9M | Sell |
71,184
-3,784
| -5% | -$807K | 0.01% | 887 |
|
|
2022
Q3 | $15M | Sell |
74,968
-600,039
| -89% | -$114M | 0.01% | 925 |
|
|
2022
Q2 | $98.5M | Buy |
675,007
+618,470
| +1,094% | +$87.7M | 0.05% | 375 |
|
|
2022
Q1 | $9.23M | Sell |
56,537
-13,343
| -19% | -$2.03M | ﹤0.01% | 1285 |
|
|
2021
Q4 | $11.8M | Buy |
69,880
+3,194
| +5% | +$594K | ﹤0.01% | 1159 |
|
|
2021
Q3 | $12.6M | Buy |
66,686
+4,765
| +8% | +$894K | 0.01% | 1124 |
|
|
2021
Q2 | $10.5M | Sell |
61,921
-5,798
| -9% | -$849K | ﹤0.01% | 1214 |
|
|
2021
Q1 | $9.56M | Sell |
67,719
-55,758
| -45% | -$8.39M | ﹤0.01% | 1226 |
|
|
2020
Q4 | $16M | Buy |
123,477
+56,687
| +85% | +$7.57M | 0.01% | 934 |
|
|
2020
Q3 | $9.72M | Sell |
66,790
-10,901
| -14% | -$1.55M | 0.01% | 1051 |
|
|
2020
Q2 | $11.5M | Buy |
77,691
+4,490
| +6% | +$605K | 0.01% | 939 |
|
|
2020
Q1 | $7.97M | Sell |
73,201
-54,587
| -43% | -$6.3M | 0.01% | 998 |
|
|
2019
Q4 | $14.7M | Buy |
127,788
+12,645
| +11% | +$1.26M | 0.01% | 919 |
|
|
2019
Q3 | $9.26M | Buy |
115,143
+11,272
| +11% | +$892K | 0.01% | 1085 |
|
|
2019
Q2 | $7.54M | Buy |
103,871
+55,080
| +113% | +$4.23M | ﹤0.01% | 1180 |
|
|
2019
Q1 | $4.56M | Sell |
48,791
-199
| -0.4% | -$16.6K | ﹤0.01% | 1427 |
|
|
2018
Q4 | $3.57M | Sell |
48,990
-698
| -1% | -$53.7K | ﹤0.01% | 1488 |
|
|
2018
Q3 | $4.35M | Sell |
49,688
-1,640
| -3% | -$165K | ﹤0.01% | 1383 |
|
|
2018
Q2 | $5.05M | Buy |
51,328
+2,045
| +4% | +$203K | ﹤0.01% | 1233 |
|
|
2018
Q1 | $5.87M | Buy |
49,283
+3,830
| +8% | +$494K | ﹤0.01% | 1129 |
|
|
2017
Q4 | $5.78M | Buy |
45,453
+1,680
| +4% | +$211K | ﹤0.01% | 1146 |
|
|
2017
Q3 | $5.14M | Sell |
43,773
-4,100
| -9% | -$350K | ﹤0.01% | 1194 |
|
|
2017
Q2 | $3.82M | Buy |
47,873
+398
| +0.8% | +$25.4K | ﹤0.01% | 1369 |
|
|
2017
Q1 | $2.43M | Sell |
47,475
-330
| -0.7% | -$15.3K | ﹤0.01% | 1669 |
|
|
2016
Q4 | $1.79M | Sell |
47,805
-2,259
| -5% | -$94.6K | ﹤0.01% | 1915 |
|
|
2016
Q3 | $3.39M | Sell |
50,064
-150
| -0.3% | -$10.6K | ﹤0.01% | 1378 |
|
|
2016
Q2 | $2.79M | Buy |
50,214
+600
| +1% | +$37.8K | ﹤0.01% | 1436 |
|
|
2016
Q1 | $3.11M | Sell |
49,614
-325
| -0.7% | -$21.6K | ﹤0.01% | 1293 |
|
|
2015
Q4 | $4.7M | Sell |
49,939
-1,185
| -2% | -$110K | ﹤0.01% | 1085 |
|
|
2015
Q3 | $4.11M | Sell |
51,124
-861
| -2% | -$95.7K | ﹤0.01% | 1147 |
|
|
2015
Q2 | $6.23M | Buy |
51,985
+3,477
| +7% | +$416K | 0.01% | 1027 |
|
|
2015
Q1 | $5.07M | Buy |
48,508
+2,970
| +7% | +$301K | ﹤0.01% | 1117 |
|
|
2014
Q4 | $4.42M | Buy |
45,538
+3,900
| +9% | +$361K | ﹤0.01% | 1174 |
|
|
2014
Q3 | $3.25M | Buy |
41,638
+500
| +1% | +$32.3K | ﹤0.01% | 1365 |
|
|
2014
Q2 | $2.6M | Sell |
41,138
-74,812
| -65% | -$4.45M | ﹤0.01% | 1585 |
|
|
2014
Q1 | $7.79M | Sell |
115,950
-5,426
| -4% | -$420K | 0.01% | 935 |
|
|
2013
Q4 | $7.81M | Sell |
121,376
-1,972
| -2% | -$118K | 0.01% | 929 |
|
|
2013
Q3 | $7.9M | Buy |
123,348
+158
| +0.1% | +$7.88K | 0.01% | 898 |
|
|
2013
Q2 | $3.82M | Buy |
+123,190
| New | +$3.28M | ﹤0.01% | 1153 |
|
Other funds holding ALNY
VPM
VCM
AllianceBernstein's ALNY Position: Q1 2026 in Review
AllianceBernstein increased its Alnylam Pharmaceuticals (ALNY) stake by 0.73% in Q1 2026, buying an estimated $110K and bringing the position to 44,641 shares worth $17.8M. The position accounts for 0.01% of the portfolio, ranked #968.
AllianceBernstein first reported a position in ALNY in Q2 2013 and has held it in 52 quarters since. The position peaked at $107M in Q1 2023. 786 funds tracked by Wall St. Rank hold ALNY as of Q1 2026.
- AllianceBernstein held 44,641 shares of Alnylam Pharmaceuticals worth $17.8M as of Q1 2026.
- AllianceBernstein bought 322 Alnylam Pharmaceuticals shares in Q1 2026, an estimated $110K.
- Alnylam Pharmaceuticals made up 0.01% of AllianceBernstein's portfolio in Q1 2026, its #968 holding.
- AllianceBernstein first reported a position in Alnylam Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- AllianceBernstein's Alnylam Pharmaceuticals position peaked at $107M in Q1 2023.
- 786 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q1 2026.
Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.